Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs

被引：0
|
作者：
M Elle Saine
Dena M Carbonari
Craig W Newcomb
Melissa S Nezamzadeh
Kevin Haynes
Jason A Roy
Serena Cardillo
Sean Hennessy
Crystal N Holick
Daina B Esposito
Arlene M Gallagher
Harshvinder Bhullar
Brian L Strom
Vincent Lo Re
机构：
[1] Perelman School of Medicine at the University of Pennsylvania,Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics
[2] Perelman School of Medicine at the University of Pennsylvania,Department of Biostatistics and Epidemiology, Center for Pharmacoepidemiology Research and Training
[3] HealthCore,Department of Medicine
[4] Inc,Rutgers Biomedical & Health Sciences
[5] Perelman School of Medicine at the University of Pennsylvania,undefined
[6] Clinical Practice Research Datalink,undefined
[7] Medicines and Healthcare Products Regulatory Agency,undefined
[8] Cegedim Strategic Data Medical Research,undefined
[9] Rutgers,undefined
[10] the State University of New Jersey,undefined
来源：
BMC Pharmacology and Toxicology | / 16卷
关键词：
Diabetes mellitus; Saxagliptin; Dipeptidyl peptidase IV inhibitor; Pharmacoepidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [11] STUDY OF PRESCRIBING PATTERN OF ANTI-DIABETIC DRUGS IN NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS
    Merry, R.
    Vijayanarayana, K.
    Girish, T.
    Nair, S.
    Rao, Karthik N.
    VALUE IN HEALTH, 2016, 19 (07) : A901 - A901
  • [12] Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer
    Haggstrom, Christel
    Van Hemelrijck, Mieke
    Zethelius, Bjorn
    Robinson, David
    Grundmark, Birgitta
    Holmberg, Lars
    Gudbjornsdottir, Soffia
    Garmo, Hans
    Stattin, Par
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (03) : 611 - 617
  • [13] Unmet needs among patients with Type 2 diabetes and secondary failure to oral anti-diabetic agents
    Pitocco, D.
    Valle, D.
    Rossi, A.
    Gentilella, R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (04) : 371 - 379
  • [14] Unmet needs among patients with Type 2 diabetes and secondary failure to oral anti-diabetic agents
    D. Pitocco
    D. Valle
    A. Rossi
    R. Gentilella
    Journal of Endocrinological Investigation, 2008, 31 : 371 - 379
  • [15] A CROSS-SECTIONAL SURVEY ON ECONOMIC BURDEN OF TYPE-2 DIABETES MELLITUS PATIENTS WITH ORAL ANTI-DIABETIC DRUGS THERAPY IN CHINA
    Ji, L.
    Ye, Q.
    Chang, J. H.
    Liu, G. G.
    VALUE IN HEALTH, 2011, 14 (03) : A96 - A96
  • [16] Triple oral anti-diabetic therapy in Type 2 diabetes
    Barnett, AH
    DIABETIC MEDICINE, 2003, 20 : 14 - 16
  • [17] The determinants of anti-diabetic medication adherence based on the experiences of patients with type 2 diabetes
    Dehdari, Laleh
    Dehdari, Tahereh
    ARCHIVES OF PUBLIC HEALTH, 2019, 77 (1)
  • [18] The determinants of anti-diabetic medication adherence based on the experiences of patients with type 2 diabetes
    Laleh Dehdari
    Tahereh Dehdari
    Archives of Public Health, 77
  • [19] Testing-and control among type 2 diabetes mellitus patients on oral anti-diabetes drugs
    Chapman, Richard H.
    Ferrufino, Cheryl P.
    Mac-Lean, John R.
    Krishnarajah, Shanthy
    DIABETES, 2008, 57 : A98 - A98
  • [20] The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes
    Quilliam, B. J.
    Ozbay, A. B.
    Sill, B. E.
    Kogut, S. J.
    DIABETIC MEDICINE, 2013, 30 (11) : 1305 - 1313
12345